North Star Investment Management Corp. Acquires New Shares in IDEX Corporation $IEX

Key Points

• North Star Investment Management acquired 4,686 IDEX shares worth approximately $1.07 million in the third quarter. Institutional investors now own 97.96% of the company.
• IDEX reported strong quarterly results, with revenue rising 8.3% year over year to $951.7 million and adjusted EPS of $2.33, beating analyst expectations.
• Management raised its outlook for 2026, forecasting 6.5%–6.8% organic sales growth and adjusted EPS of $8.91–$8.96. Analysts maintain a broadly positive view, with a “Moderate Buy” consensus and average price target of $263.64.

North Star Investment Management Corp. acquired a new position in IDEX Corporation (NYSE:IEX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 4,686 shares of the industrial products company's stock, valued at approximately $1,068,000.

A number of other large investors have also recently made changes to their positions in the business. BlackRock Inc. purchased a new stake in IDEX in the second quarter worth $1,301,393,000. Primecap Management Co. CA bought a new stake in IDEX in the second quarter valued at $748,951,000. Bank of America Corp DE boosted its holdings in IDEX by 215.0% in the first quarter. Bank of America Corp DE now owns 1,094,101 shares of the industrial products company's stock valued at $207,387,000 after acquiring an additional 746,732 shares in the last quarter. Alyeska Investment Group L.P. increased its position in IDEX by 101.4% during the 2nd quarter. Alyeska Investment Group L.P. now owns 1,042,703 shares of the industrial products company's stock valued at $236,641,000 after purchasing an additional 525,048 shares during the period. Finally, Freestone Grove Partners LP purchased a new position in IDEX during the 2nd quarter valued at $102,523,000. 97.96% of the stock is currently owned by institutional investors.

Insider Buying and Selling at IDEX

In related news, CAO Lisa Anderson sold 385 shares of the business's stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total value of $91,857.15. Following the completion of the transaction, the chief accounting officer directly owned 4,327 shares in the company, valued at $1,032,378.93. The trade was a 8.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.50% of the stock is owned by company insiders.

Key Stories Impacting IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Q3 results exceeded expectations: IDEX reported quarterly revenue of $951.7 million, up 8.3% year over year and above the $934.4 million consensus estimate. Adjusted EPS of $2.33 also topped expectations of approximately $2.24 and rose from $2.03 in the prior-year quarter. IDEX Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Outlook was raised: Management forecast 2026 organic sales growth of 6.5% to 6.8% and adjusted diluted EPS of $8.91 to $8.96, supported by momentum in advantaged markets. Third-quarter orders increased 13% year over year to $991.2 million, suggesting healthy demand. IDEX Raises 2026 Outlook
• Positive Sentiment: Operating performance remained solid: Health & Science Technologies sales rose 14%, while operating cash flow increased to $239.5 million from $203.5 million. IDEX also returned $129 million to shareholders through dividends and share repurchases. IDEX Posts Record Third-Quarter Sales
• Positive Sentiment: Analysts remain constructive: Stifel raised its price target from $267 to $273 and maintained a “buy” rating, implying additional upside from current trading levels. Stifel Raises IDEX Price Target
• Neutral Sentiment: RBC trimmed its price target modestly from $285 to $283 but retained an “outperform” rating, indicating that its valuation view remains favorable despite the adjustment. RBC Trims IDEX Price Target
• Negative Sentiment: Recent insider activity cited in the coverage showed selling by company executives and no open-market insider purchases over the past six months, a modest cautionary signal for investors.

IDEX Stock Performance

Shares of IDEX stock opened at $239.67 on Friday. The stock has a market cap of $17.67 billion, a price-to-earnings ratio of 33.29, a PEG ratio of 2.67 and a beta of 0.97. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.78 and a quick ratio of 2.15. IDEX Corporation has a 1 year low of $160.60 and a 1 year high of $243.80. The firm's 50-day moving average is $230.11 and its 200 day moving average is $215.72.

IDEX (NYSE:IEX - Get Free Report) last issued its earnings results on Wednesday, October 28th. The industrial products company reported $2.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.09. The business had revenue of $951.70 million during the quarter, compared to analysts' expectations of $934.36 million. IDEX had a net margin of 14.65% and a return on equity of 16.18%. The business's revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.03 earnings per share. Sell-side analysts anticipate that IDEX Corporation will post 8.92 EPS for the current fiscal year.

IDEX Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 16th. Investors of record on Friday, October 2nd were given a dividend of $0.73 per share. The ex-dividend date of this dividend was Friday, October 2nd. This represents a $2.92 annualized dividend and a dividend yield of 1.2%. IDEX's dividend payout ratio (DPR) is 42.01%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Stifel Nicolaus raised their target price on shares of IDEX from $267.00 to $273.00 and gave the stock a "buy" rating in a research report on Thursday. Mizuho raised shares of IDEX from a "neutral" rating to an "outperform" rating and lifted their target price for the company from $210.00 to $280.00 in a research note on Tuesday, August 11th. Weiss Ratings reiterated a "buy (b-)" rating on shares of IDEX in a research report on Wednesday. TD Cowen boosted their price target on shares of IDEX from $260.00 to $275.00 and gave the company a "buy" rating in a research report on Thursday, July 30th. Finally, DA Davidson set a $245.00 price target on shares of IDEX in a research note on Thursday. Nine research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $263.64.

IDEX Profile

IDEX Corporation is an industrial manufacturing company headquartered in Lake Forest, Illinois. The company designs and produces engineered products and technologies used to move, control, measure and apply fluids, as well as equipment used in fire and safety applications.

IDEX operates through businesses serving fluid and metering technologies, health and science technologies, and fire and safety markets. Its products include pumps, valves, flow meters, compressors, dispensing equipment, precision fluidics components and systems, fire pumps, rescue tools and other specialized equipment.

The company serves a broad range of industries, including healthcare, life sciences, water and wastewater, chemical processing, energy, food and beverage, agriculture, industrial manufacturing and municipal fire protection.

Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.